FNY Partners Fund’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

FNY Partners Fund’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,000	Closed	-$359K	–	563
2017 Q4	$359K	Buy	+20,000	New	+$246K	0.06%	106

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

FNY Partners Fund's SCMP Position: Q1 2018 in Review

FNY Partners Fund sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 20,000 shares — an estimated $359K sold.

FNY Partners Fund first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $359K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

FNY Partners Fund reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
FNY Partners Fund sold 20,000 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $359K.
FNY Partners Fund first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
FNY Partners Fund's Sucampo Pharmaceuticals, Inc. position peaked at $359K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.